Mission Possible

This is where it all starts.

Braeburn makes it possible for independent minds, trailblazers and innovators to work together in a unique environment that encourages innovation and discovery. We believe this is the difference that makes a difference.

Perhaps it’s the promise that our vision can actually be attained. Not through politics or committees, but through mutual understanding, drive, and purpose.

Every day, we’re reevaluating and rethinking a new way forward… to redefine treatment.

Braeburn is thinking beyond what’s been done. And thinking about what can be done, what is possible…

Possible starts here.

About Us

Braeburn Pharmaceuticals, a phase III specialty pharmaceutical company, focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia.

The Opioid Epidemic
Learn more about the opioid dependence epidemic in America
Dr. Matt Torrington talks about the current state of opioid addiction and treatment in America

 

#2 

Opioid overdose is the second leading cause of unintentional deaths in the US.

80% 

of the world’s opioids are used
by Americans.

75% 

of medication overdose deaths
in 2010 were related to opioid drugs.

Learn more

New Approaches to Opioid Dependence

Braeburn is working every day to help fight the ever-growing epidemic of opioid dependence. Register to receive updates from Braeburn Pharmaceuticals as they are made available.

register_hp